Zhu Y, Liu F, Liu L, Wang J, Gao F, Ye L
J Zhejiang Univ Sci B. 2025; 26(1):76-91.
PMID: 39815612
PMC: 11735908.
DOI: 10.1631/jzus.B2300896.
Frame G, Huang X, Haas R, Khan K, Leong H, Kislinger T
Sci Rep. 2024; 14(1):31205.
PMID: 39732766
PMC: 11682066.
DOI: 10.1038/s41598-024-82546-w.
Liu Y, Yang J, Weng D, Xie Y
Int J Mol Sci. 2024; 25(7).
PMID: 38612387
PMC: 11011687.
DOI: 10.3390/ijms25073576.
Hurd M, Pino J, Jang K, Allevato M, Vorontchikhina M, Ichikawa W
Genes Dev. 2023; 37(19-20):865-882.
PMID: 37852796
PMC: 10691474.
DOI: 10.1101/gad.350736.123.
Girish V, Lakhani A, Thompson S, Scaduto C, Brown L, Hagenson R
Science. 2023; 381(6660):eadg4521.
PMID: 37410869
PMC: 10753973.
DOI: 10.1126/science.adg4521.
Blebs promote cell survival by assembling oncogenic signalling hubs.
Weems A, Welf E, Driscoll M, Zhou F, Mazloom-Farsibaf H, Chang B
Nature. 2023; 615(7952):517-525.
PMID: 36859545
PMC: 10881276.
DOI: 10.1038/s41586-023-05758-6.
Oncogene-like addiction to aneuploidy in human cancers.
Girish V, Lakhani A, Scaduto C, Thompson S, Brown L, Hagenson R
bioRxiv. 2023; .
PMID: 36711674
PMC: 9882055.
DOI: 10.1101/2023.01.09.523344.
Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties.
McCubrey J, Meher A, Akula S, Abrams S, Steelman L, Lahair M
Aging (Albany NY). 2022; 14(8):3365-3386.
PMID: 35477123
PMC: 9085237.
DOI: 10.18632/aging.204038.
DCAF12 promotes apoptosis and inhibits NF-κB activation by acting as an endogenous antagonist of IAPs.
Jiao D, Chen Y, Wang Y, Sun H, Shi Q, Zhang L
Oncogene. 2022; 41(21):3000-3010.
PMID: 35459779
DOI: 10.1038/s41388-022-02319-5.
Three-Dimensional Modelling of Ovarian Cancer: From Cell Lines to Organoids for Discovery and Personalized Medicine.
Yee C, Dickson K, Muntasir M, Ma Y, Marsh D
Front Bioeng Biotechnol. 2022; 10:836984.
PMID: 35223797
PMC: 8866972.
DOI: 10.3389/fbioe.2022.836984.
PEST domain variants are responsive to standard of care treatments despite distinct transformative properties in a breast cancer model.
Cravero K, Pantone M, Shin D, Bergman R, Cochran R, Chu D
Oncotarget. 2022; 13:373-386.
PMID: 35186194
PMC: 8849273.
DOI: 10.18632/oncotarget.28200.
A proteomic investigation of isogenic radiation resistant prostate cancer cell lines.
Kurganovs N, Wang H, Huang X, Ignatchenko V, Macklin A, Khan S
Proteomics Clin Appl. 2021; 15(5):e2100037.
PMID: 34152685
PMC: 8448965.
DOI: 10.1002/prca.202100037.
IR-Surviving NSCLC Cells Exhibit Different Patterns of Molecular and Cellular Reactions Relating to the Multifraction Irradiation Regimen and p53-Family Proteins Expression.
Alhaddad L, Pustovalova M, Blokhina T, Chuprov-Netochin R, Osipov A, Leonov S
Cancers (Basel). 2021; 13(11).
PMID: 34071477
PMC: 8198560.
DOI: 10.3390/cancers13112669.
Progenitor Cells Activated by Platelet Lysate in Human Articular Cartilage as a Tool for Future Cartilage Engineering and Reparative Strategies.
Carluccio S, Martinelli D, Palama M, Pereira R, Benelli R, Guijarro A
Cells. 2020; 9(4).
PMID: 32340136
PMC: 7226425.
DOI: 10.3390/cells9041052.
Overexpression of CD36 in mammary fibroblasts suppresses colony growth in breast cancer cell lines.
Cheng Q, Jabbari K, Winkelmaier G, Andersen C, Yaswen P, Khoshdeli M
Biochem Biophys Res Commun. 2020; 526(1):41-47.
PMID: 32192771
PMC: 7188558.
DOI: 10.1016/j.bbrc.2020.03.061.
TrkA overexpression in non-tumorigenic human breast cell lines confers oncogenic and metastatic properties.
Kyker-Snowman K, Hughes R, Yankaskas C, Cravero K, Karthikeyan S, Button B
Breast Cancer Res Treat. 2019; 179(3):631-642.
PMID: 31823098
PMC: 7337566.
DOI: 10.1007/s10549-019-05506-3.
Stiffness Sensing by Cells.
Janmey P, Fletcher D, Reinhart-King C
Physiol Rev. 2019; 100(2):695-724.
PMID: 31751165
PMC: 7276923.
DOI: 10.1152/physrev.00013.2019.
Friend or foe-IDH1 mutations in glioma 10 years on.
Huang L
Carcinogenesis. 2019; 40(11):1299-1307.
PMID: 31504231
PMC: 6875900.
DOI: 10.1093/carcin/bgz134.
The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling.
Cui Y, Groth S, Troutman S, Carlstedt A, Sperka T, Riecken L
Oncogene. 2019; 38(36):6370-6381.
PMID: 31312020
PMC: 6756068.
DOI: 10.1038/s41388-019-0883-6.
Identifying chemopreventive agents for obesity-associated cancers using an efficient, 3D high-throughput transformation assay.
Benham V, Bullard B, Dexheimer T, Bernard M, Neubig R, Liby K
Sci Rep. 2019; 9(1):10278.
PMID: 31311976
PMC: 6635484.
DOI: 10.1038/s41598-019-46531-y.